Skip to content

Emotional Well-being and Measures of Healthy Aging

Emotional Well-being and Biomarkers of Healthy Aging

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07334106
Enrollment
80
Registered
2026-01-12
Start date
2025-09-01
Completion date
2028-08-31
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Aging, Biological, Aging, Healthy, Aging Well

Keywords

Aging, Resilience, Psychological, Psychological Well-Being, Aging Well, Internet-Based Intervention

Brief summary

This randomized control study is designed to understand the role of a positive psychology intervention (PARK: Positive Affect Regulation sKills) in biological aging and well-being. PARK provides a series of positive emotion skills in a self-guided online format, making the program accessible and convenient. Our main aims are: Aim 1: To explore the effects of PARK on psychological well-being (e.g., depression, anxiety, positive affect). Aim 2: To explore the effects of PARK on biological age as defined by DNA methylation (DNAm) GrimAge and electrocardiogram-age (ECG-age), as well as physiological well-being in adults (e.g., cardiovascular, endocrine, musculoskeletal functioning, etc.).

Detailed description

The skills in the Positive Psychology Intervention (PPI), PARK (e.g., gratitude, mindful awareness and nonjudgement, and self-compassion) are designed to promote positive emotion, which has been shown to provide resilience against stress. Positive emotion, independent of stress and negative emotion, has also been associated with a lower risk of mortality and better health behaviors such as likelihood of physical activity and healthy eating. This randomized control study will compare baseline well-being scores to post-online intervention at 3 months, 6 months, and 12 months post-baseline. Secondarily, measures of biological aging (DNAm GrimAge and ECG-age) and physiological functioning measures of cardiovascular, musculoskeletal, and endocrine functioning will be explored from baseline to post-intervention measures 3 and 12 months later. Research will be based in Northwestern's Feinberg School of Medicine through the Potocsnak Human Longevity Lab and the Department of Medical Social Sciences (MSS), with all study procedures conducted in-person at the Human Longevity Lab or online. Eligibility screening, consent, and assessments will be conducted on REDCap. Consenting participants randomized to the treatment group will receive access to the online PARK platform within two weeks. The intervention consists of a positive skills course (including weekly lessons and daily skills practice) and daily emotion check-ins, hosted by BrightOutcome. The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access.

Interventions

BEHAVIORALPositive Emotion Skills Intervention

Skills include positive events, capitalizing, gratitude, mindfulness, positive reappraisal, personal strengths, achievable goals, and self-compassion. The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access. A week will consist of 1-2 days of didactic material and 5-6 days of real-life skills practice and reporting. Participants cannot skip ahead and can only progress to the next lesson if they have completed the current one, but they can return to old lessons or exercises if they wish to.

Sponsors

Potocsnak Human Longevity Lab
CollaboratorUNKNOWN
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Intervention model description

This study is a waitlist-control design. Participants in the control participant will receive the positive psychology intervention at the conclusion of the study.

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 40-70 * Speaks and reads English * Able to access the online platform through their phone, a public device (i.e., at the library) or at home. * Lives in the Chicagoland area * Willing/able to travel to the Human Longevity Lab for in-person visits

Exclusion criteria

* Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners * Vulnerable Populations * Pre-existing heart disease (prevalent coronary heart and cerebrovascular disease or heart failure) * Type 2 diabetes * Severe psychiatric illness

Design outcomes

Primary

MeasureTime frameDescription
Patient-Reported Outcomes Measurement Information System (PROMIS) Positive Affect (v1.0) and PROMIS Meaning and Purpose (v1.0)Baseline, 3 months, 6 months, 12 monthsComputer Adaptive Testing measure of positive emotion and purpose. Higher scores mean a better outcome (i.e., more positive emotion). Scores can range from 9-85, and a t-score of 50 represents the mean score for the United States general population with a standard deviation of 10.
PROMIS Depression (v1.0), Anxiety (v1.0), Social Isolation (v2.0)baseline and 3, 6, 12 months post-baselineComputer Adaptive Testing measures of psychosocial well-being. Higher scores mean a worse outcome (i.e., more anxiety or depression). Scores can range from 9-85, and a t-score of 50 represents the mean score for the United States general population with a standard deviation of 10.

Secondary

MeasureTime frameDescription
Biological Age: DNA methylation GrimAgeBaseline, 3 months, 12 monthsBiological age as defined by DNA methylation GrimAge, an estimation of biological age in units of years.
ECG-age (electrocardiogram-age)Baseline, 3 months, 12 monthsArtificial intelligence algorithm using electrocardiogram data to estimate participant's age in unit of years. Higher ECG-age equates to greater cardiovascular aging.
Telomere LengthBaseline, 3 months, 12 monthsTelomere length measures cellular aging, measured in kilobases (kb). Longer telomere length indicates less cellular aging (a better outcome).

Countries

United States

Contacts

Primary ContactChelsea S Brown
chelsea.brown@northwestern.edu312-503-3712

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026